Repligen | الدين



Debt تغيير تاريخ
Agilent USD 3.36B 27M 2025-01
Align Technology USD 0 0 2024-12
Bio Techne USD 300M 0 2024-12
BioMarin Pharmaceutical USD 596.24M 1.61M 2024-12
Bristol-Myers Squibb USD 49.65B 103M 2024-12
Bruker USD 2.09B 203M 2024-12
Charles River Laboratories USD 2.24B 86.72M 2024-12
Danaher USD 16.01B 1.52B 2024-12
Dentsply International USD 2.14B 82M 2024-12
Exact Sciences USD 2.59B 8K 2024-12
General Electric USD 19.27B 649M 2024-12
Henry Schein USD 2.54B 117M 2024-12
Illumina USD 1.99B 1000K 2024-12
IQVIA Holdings USD 13.98B 471M 2024-12
Mettler Toledo International USD 2.01B 63.6M 2024-12
Myriad Genetics USD 39.6M 600K 2024-12
Patterson Companies USD 750.64M 66.24M 2025-01
Pfizer USD 64.35B 3.35B 2024-12
Repligen USD 521.61M 221.25M 2024-09
Revvity USD 3.15B 36.03M 2024-12
Standard Biotools USD 299K 54.91M 2024-12
Thermo Fisher Scientific USD 31.28B 4.04B 2024-12
Waters USD 1.63B 199.76M 2024-12
West Pharmaceutical Services USD 205.6M 100K 2024-12



Repligen الدين - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Mar 2025.